Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

February 6, 2019

Precision Radiation Therapy to Treat Prostate Cancer Spread Safe for High-Risk Patients, Phase 2 Trial Finds

News

Prostate cancer patients at a high risk of tumor spreading can safely receive high-dose radiation therapy that targets both the prostate and neighboring pelvic lymph nodes, a Phase 2 ... Read more

January 30, 2019January 30, 2019

FDA Clears Phase 1 Trial of ARV-110 for Advanced Prostate Cancer

News

The U.S. Food and Drug Administration has signed off on Arvinas‘ first Phase 1 clinical trial to evaluate ARV-110 as a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). ... Read more

January 16, 2019

Coffee and Tea Intake Not Linked to Prostate Cancer Risk, According to Large European Study

News

Drinking tea or coffee, with or without caffeine, has no impact on the risk for prostate cancer, according to the results of a large European study. The study, “Coffee ... Read more

January 10, 2019

Phase 2 Trial of Tomivosertib Begins Dosing Advanced Castration-resistant PC Patients

News

A Phase 2 clinical trial evaluating eFFECTOR Therapeutics’ investigational therapy tomivosertib (eFT508), for men with advanced castrate-resistant prostate cancer (CRPC) who failed to respond to androgen receptor signaling (ARS) inhibitors, has ... Read more

December 12, 2018

Phase 3 Trial Testing New Imaging Agent for Prostate Cancer Detection Doses First Patient

News

A Phase 3 trial evaluating Progenics Pharmaceuticals‘ new imaging agent to help detect prostate cancer recurrence has begun dosing participants. The agent, called PyL (18F-DCFPyl), is a tracing substance composed of the ... Read more

December 6, 2018

New Imaging Agent Better at Detecting Signs of Prostate Cancer Recurrence, Study Reports

News

A new imaging agent for use in positron emission tomography (PET) is better than conventional imaging at detecting cancer location and spread in prostate cancer patients suspected of cancer ... Read more

September 5, 2018

Higher Radiotherapy Doses But Fewer Treatment Sessions May Be Possible, Early Trial Data Suggest

News

Prostate cancer patients may benefit from a new form of radiation therapy that delivers larger doses per session but in a much shorter treatment course, and when used in ... Read more

August 8, 2018

Simple Blood Test Could Determine Best Treatment Option for Advanced Prostate Cancer, Study Says

News

A blood test that examines circulating tumor cells for the presence of the AR-V7 protein could help determine if a patient with advanced prostate cancer would fare better with ... Read more

June 4, 2018

Laser-guided Treatment Better in Long Term than Monitoring for Low-risk Prostate Cancer, New Phase 3 Data Show

News

Prostate cancer patients who undergo a nonsurgical procedure to remove part of their prostate gland — using a kind of photodynamic therapy targeting the blood vessels — fare better ... Read more

May 7, 2018

Exposure to Blue Light at Night May Increase Risk of Prostate, Breast Cancer, Study Says

News

Exposure to artificial light at night, such as the blue light emitted by most LEDs and computer and smartphone screens, may increase the risk of developing prostate cancer and ... Read more

Pin It on Pinterest